LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients

Lancet. 2003 Mar 29;361(9363):1099-101. doi: 10.1016/S0140-6736(03)12855-3.

Abstract

Human cytomegalovirus infection is a major cause of morbidity after lung transplantation. LIR-1 (leucocyte immunoglobulin-like receptor-1) is an inhibitory cell surface receptor that has high affinity for an MHC class I homologue (UL18) encoded by human cytomegalovirus. We aimed to investigate whether reactivation of human cytomegalovirus affects the expression of LIR-1. We measured LIR-1 expression on peripheral blood lymphocytes from 13 lung-transplant recipients and established human cytomegalovirus load using PCR. Eight patients developed cytomegalovirus disease. The percentage of cells expressing LIR-1 increased in the patients who developed cytomegalovirus disease several weeks before viral DNA was detectable by PCR. Measurement of LIR-1 expression might allow early identification of cytomegalovirus disease in lung-transplant patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antigens, CD / blood*
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / immunology*
  • Female
  • Follow-Up Studies
  • Humans
  • Immune Tolerance / immunology
  • Leukocyte Immunoglobulin-like Receptor B1
  • Lung Transplantation / immunology*
  • Lymphocytes / immunology*
  • Male
  • Middle Aged
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / immunology*
  • Receptors, Immunologic / blood*
  • Risk Factors

Substances

  • Antigens, CD
  • LILRB1 protein, human
  • Leukocyte Immunoglobulin-like Receptor B1
  • Receptors, Immunologic